Peptides’ role in autism with emphasis on exorphins

References

• Folstein H, Rutter M. Infantile autism: a genetic study of 21 twin pairs. J Child Psychol Psychiatry. 1975; 113: 297–321.
   Google Scholar
• Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med. 1995; 25: 63–77. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• Garrecht M, Austin DW. The plausibility of a role for mercury in the etiology of autism: a cellular perspective. Toxicol Environ Chem. 2011; 93: 1251–73. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• Nataf R, Skorupka C, Amet L, Lam A, Springbett A, Lathe R. Porphyrinuria in childhood autistic disorder: implications for environmental toxicity. Toxicol Appl Pharmacol. 2006; 214: 99–108. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• Yong LJ, Pitkow LJ, Ferguson IN. The neuropatho-genesis of mercury toxicity. Mol Psychiatry. 2002; 7: 540–1. 10.3402/mehd.v23i0.18958.
   Google Scholar
• Reichelt KL, Knivsberg AM, Lind G, Nødland M. Probable etiology and possible treatment of childhood autism. Brain Dysfunct. 1991; 4: 308–19.
   Google Scholar
• Shattock P, Kennedy A, Rowell F, Berney T. Role of neuropeptides in autism and their relationship with classical neurotransmitters. Brain Dysfunct. 1990; 3: 328–45.
   Google Scholar
• Cade RJ, Privette RM, Fregly M, Rowland N, Sun Z, Zele V, et al. Autism and schizophrenia: intestinal disorders. Nutr Neurosci. 2000; 3: 57–72.
   PubMed Web of Science ®Google Scholar
• Shanahan MR, Venturini AJ, Daiss JL, Friedman AE. Peptide diagnostic markers for human disorders. European Patent Application. 2000; EP 0 969 015 A2: 1–44.
   Google Scholar
• Kost NV, Sokolov OY, Kurasova OB, Dimitriev AD, Tarakanova JN, Gabaeva MV, et al. Beta-casomorphin-7 in infants on different type of feeding and different levels of psychomotor development. Peptides. 2009; 30: 854–60. 10.3402/mehd.v23i0.18958.
   Google Scholar
• Reichelt KL, Knivsberg AM. Can the pathophysiology of autism be explained by the nature of the discovered urine peptides?. Nutr Neurosci. 2003; 6: 19–28. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• Sacco R, Curatolo P, Manzi B, Militerni R, Bravaccio C, Frolli A, et al. Principal pathogenetic components and biological endophenotypes in autism spectrum disorders. Autism Res. 2010; 3: 237–52. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• Sponheim E, Myhre AM, Reichelt KL, Aasen OC. Peptidmønstre I urin hos barn med mildere former for autisme. Tidsskr Nor Laegeforen. 2006; 126: 1475–7.
   Google Scholar
• Reichelt KL, Hole K, Hamberger A, Sælid G, Edminson PD, Braestrup CB, et al. Biologically active peptide-containing fractions in schizophrenia and childhood autism. Adv Biochem Psychopharmacol. 1981; 28: 627–98.
   PubMedGoogle Scholar
• Hole K, Bergslien AA, Jørgensen H, Berge OG, Reichelt KL, Trygstad OE. A peptide containing fraction from schizophrenia which stimulates opiate receptors and inhibits dopamine uptake. Neuroscience. 1979; 4: 1139–47. 10.3402/mehd.v23i0.18958.
   Web of Science ®Google Scholar
• Sun Z, Cade JR. A peptide found in schizophrenia and autism causes behavioural changes in rats. Autism. 1999; 3: 85–95. 10.3402/mehd.v23i0.18958.
   Google Scholar
• Sun Z, Cade RJ, Fregly MJ, Privette RM. Beta-casomorphine induces fos-like immunoreactivity in discrete brain regions relevant to schizophrenia and autism. Autism. 1999; 3: 67–83. 10.3402/mehd.v23i0.18958.
   Google Scholar
• Reichelt KL, Ekrem J, Scott H. Gluten, milk proteins and autism: dietary intervention effects on behavior and peptide secretion. J Appl Nutr. 1990; 42: 1–11.
   Google Scholar
• Kawashti MI, Amin OH, Rowely NG. Possible immunological disorders in autism. Concomittant autoimmunity and immune tolerance. Egypt J Immunol. 2008; 13: 99–104.
   Google Scholar
• Trajkovski V, Petlichkovski A, Efinska-Mladenovska O, Trajkov D, Arsov T, Strzova A, et al. Higher plasma concentrations of food specific antibodies in persons with autistic disorder in comparison to their siblings. Focus on Autism and Other Developmental Disabilities. 2008; 23: 176–86. 10.3402/mehd.v23i0.18958.
   Web of Science ®Google Scholar
• Voidani A, O'Bryan T, Green JA, McCandless J, Woeller KN, Vojdani AA, et al. Immune response to dietary proteins, Gliadin and Cerebellar Peptides in Children with Autism. Nutritional Neurosci. 2004; 7: 151–61. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• Panksepp J, Normansell L, Sivily S, Rossi J, Zolovick AJ. Casomorphins reduce separation distress in chickens. Peptides. 1978; 5: 829–31. 10.3402/mehd.v23i0.18958.
   Web of Science ®Google Scholar
• Svedberg J, De Haas J, Leimanstoll G, Paul F, Teschemacher H. Demonstration of beta-casomorphin immunoreactive materials in vitro digests of bovine milk and in small intestinal contents after bovine milk ingestion in adult humans. Peptides. 1985; 6: 825–31. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• Chabance B, Marteau P, Rambaud JC, Migliore-Samour D, Boynard M, Perrotin P, et al. Casein peptides release and passage to the blood in humans during digestion of milk and yogurt. Biochimie. 1998; 80: 155–65. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• Gardner MLG. Absorption of intact proteins and peptides. Physiology of the Gastrointestinal Tract. Johnson LR. Raven Press: New York, 1994; 1795–820.
   Google Scholar
• Mahe S, Tome D, Demontier AM, Desjeux JF. Absorption of intact morphiceptin by diisopropylflurophosphate – treated rabbit ileum. Peptides. 1989; 10: 45–52. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• Bouras M, Huneau JF, Tome D. The inhibition of intestinal dipeptidylaminopeptidase-IV promotes the absorption of enterostatin and des-arginine-enterostain across rat jejunum in vitro. Life Sci. 1996; 59: 2147–55. 10.3402/mehd.v23i0.18958.
   Google Scholar
• Kastin AJ, Nissen C, Schally AV, Coy DH. Additional evidence that small amounts of a peptide can cross the blood–brain barrier. Pharmacol Biochem Behav. 1979; 14: 717–9. 10.3402/mehd.v23i0.18958.
   Google Scholar
• Ermisch A, Brust P, Kretzchmar R, Buhle HJ. On the blood–brain barrier to peptides (3H) beta-casomorphin-5 uptake by eighteen brain regions in vivo. J Neurochem. 1983; 41: 1229–33. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• Husby S, Jensenius JC, Cant AJ. Passage of un-degraded dietary antigen into the blood of healthy adults. Scand J Immunol. 1984; 22: 83–92. 10.3402/mehd.v23i0.18958.
   Web of Science ®Google Scholar
• Seifert J, Ganser R, Brebdel W. Die resorption eines proteolytisches proteins pflanzlichen ursprunge aus dem magen-darm-trakt in das blut und in die lymphe von erwachsenen ratten. Z Gastroenterol. 1979; 17: 1–8.
   PubMed Web of Science ®Google Scholar
• Axelsson I, Jacobsson I, Lindberg T, Benediktsson B. Bovine lactoglobulin in human milk. Acta Paediatr Scand. 1986; 75: 702–7. 10.3402/mehd.v23i0.18958.
   PubMedGoogle Scholar
• Troncone F, Scarcello A, Donatiello A, Cannataro P, Tabusco A, Auricchio S. Passage of gliadin into human breast milk. Acat Paediatr Scand. 1987; 76: 453–6. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• Langer SZ. 25 years since the discovery of presynaptoic receptors: present knowledge and future perspectives. Trends Pharmacol Sci. 1997; 18: 95–9. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• Hadjivassiliou M, Boscolo S, Davies-Jones GAB, Grünewald RA, Not T, Sanders DS, et al. The humoral response in the pathogenesis of gluten ataxia. Neurology. 2002; 58: 1221–6. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• Horvath K, Papadimitriou JC, Rabaztyn A, Drachenberg C, Tildon IT. Gastrointestinal abnormalities in children with autistic disorder. J Pediatr. 1999; 135: 559–63. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• Torrente F, Ashwood P, Day R, Marchado N, Furlano RI, Anthony A, et al. Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry. 2002; 7: 375–82. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• Wakefield AJ, Anthony A, Murch SH, Thomson M, Montgomery SM, Davies S, et al. Enerocolitis in children with developmental disorders. Am J Gastroenterol. 2000; 95: 2285–95. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• Jyonouchi H, Sun S, Itokazu N. Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology. 2002; 46: 76–84. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• Heyman M, Desjeux JF. Cytokine-induced alteration of epithelial barrier to food antigens in disease. Ann NY Acad Sci. 2000; 915: 304–11. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• D'Eufemia P, Celli M, Finnochiaro R, Pacifico L, Viozzi L, Zaccagnini M, et al. Abnormal intestinal permeability in children with autism. Acta Paediatr. 1996; 85: 1076–9. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• de Magistris L, Familian V, Pascotto A, Sapone A, From A, Iardino P, et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and their first-degree relatives. J Pediatr Gastroenterol Nutr. 2010; 51: 418–24. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• Knivsberg A-M, Wiig K, Lind G, Nødland M, Reichelt KL. Dietary intervention in Autistic syndromes. Brain Dysfunction. 1990; 3: 315–27.
   Google Scholar
• Lucarelli S, Frediani T, Zingoni AM, Ferruzzi F, Giardini O, Quintieri F, et al. Food allergy and infantile autism. Panminerva Med. 1995; 37: 137–41.
   PubMed Web of Science ®Google Scholar
• Whiteley P, Rodgers J, Savery D, Shattock PA. A gluten-free diet as an intervention for autism and associated spectrum disorders: preliminary findings. Autism. 1999; 3: 45–65. 10.3402/mehd.v23i0.18958.
   Google Scholar
• Klaveness J, Bigam J. The GFCF kids diet survey. In: The autism Res Unit. Sunderland Univ, ed. Building bridges. 2002, pp. 77–84.
   Google Scholar
• Rimland B. Parent rating of behavioral effects of biomedical interventions. ARI publ. 2003: 34.
   Google Scholar
• Kniker WT, Andrews A, Hundley A, Garver C. The possible role of intolerance to milk/dairy and wheat/gluten foods in older children and adults with autism spectrum disorder. The autism Res. Unit, Sunderland Univ, ed. ‘2001: An Autism odyssey’. 2001, pp. 183–91.
   Google Scholar
• Brudnak MA, Rimland B, Kerry RE, Dailey M, Taylor R, Stayton B, et al. Enzyme-based therapy for autism spectrum disorders-is it worth another look?. Med Hypothesis. 2002; 58: 422–8. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• Whiteley P, Haracopos D, Knivsberg A-M, Reichelt KL, Parlar S, Jacobsen J, et al. The Scan Brit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders. Nutrit Neurosci. 2010; 13(2): 87–100. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• Pennesi CM, Klein LC. Effectiveness of the gluten free, caseiun free diet for children diagnosed with autism spectrum disorder.Based on parental report. Nutrit. Neurosci. 2012; 15(2): 85–91.
   PubMed Web of Science ®Google Scholar
• Knivsberg A-M. Reichelt KL. Høien T. Nødland M. A randomized, controlled study of dietary intervention in Autistic syndromes. Nutrit. Neurosci. 2002; 5: 251–61. 10.3402/mehd.v23i0.18958.
   PubMed Web of Science ®Google Scholar
• Knivsberg A-M, Reichelt KL, Nødland M, Høien T. Austistic sundromes and diet: a follow-up study. Scand J. Educat. Res. 1995; 39: 223–36. 10.3402/mehd.v23i0.18958.
   Google Scholar